AbstractIntroduction22q11.2 deletion syndrome (22q11DS) represents one of the largest known genetic risk factors for psychosis, yet the neurobiological mechanisms underlying symptom development are not well understood. Here we conducted a cross-sectional study of 22q11DS to decompose cortical volume into its constituent parts, cortical thickness (CT) and surface area (SA), which are believed to have distinct neurodevelopmental origins.MethodsHigh-resolution T1-weighted scans were collected on 65 participants (31 22q11DS, 34 demographically comparable typically developing controls, 10–25years old). Measures of cortical volume, CT, and SA were extracted from regions of interest using the FreeSurfer image analysis suite. Group differences and ...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors for...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors ...
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia duri...
Introduction22q11.2 deletion syndrome (22q11DS) represents one of the largest known genetic risk fac...
Schizophrenia has been extensively associated with reduced cortical thickness (CT), and its neurodev...
22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion in humans, with a heterogenou...
22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion in humans, with a heterogenou...
Background. Patients with 22q11.2 deletion syndrome (22q11DS) present a high risk of developing psyc...
Introduction Subjects with 22q11.2 deletion syndrome (22g11 DS) and subjects with ultra-high risk fo...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The primary objective of the current prospective study was to examine developmental patterns of voxe...
The 22q11.2 deletion syndrome (velocardiofacial/DiGeorge syn-drome, 22q11.2DS) involves cardiac and ...
22q11.2 deletion syndrome (22q11DS) is associated with an increased susceptibility to develop schizo...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors for...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors ...
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia duri...
Introduction22q11.2 deletion syndrome (22q11DS) represents one of the largest known genetic risk fac...
Schizophrenia has been extensively associated with reduced cortical thickness (CT), and its neurodev...
22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion in humans, with a heterogenou...
22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion in humans, with a heterogenou...
Background. Patients with 22q11.2 deletion syndrome (22q11DS) present a high risk of developing psyc...
Introduction Subjects with 22q11.2 deletion syndrome (22g11 DS) and subjects with ultra-high risk fo...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for ps...
The primary objective of the current prospective study was to examine developmental patterns of voxe...
The 22q11.2 deletion syndrome (velocardiofacial/DiGeorge syn-drome, 22q11.2DS) involves cardiac and ...
22q11.2 deletion syndrome (22q11DS) is associated with an increased susceptibility to develop schizo...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors for...
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors ...
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia duri...